Latest news
Recon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMTEli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally - Bloomberg.comBloomberg.com · Tue, 04 Aug 2026 11:00:05 GMTEli Lilly Weighs Stock Split as Obesity Drug Revenue Drives Historic Market Rally - streamlinefeed.co.kestreamlinefeed.co.ke · Tue, 04 Aug 2026 11:00:05 GMT